	US 12,329,804 B2
	Modified chemokine peptide and use thereof
Jya-Wei Cheng, Tainan (TW); Hsi-Tsung Cheng, Tainan (TW); Hui-Yuan Yu, Tainan (TW); and Su-Ya Hsu, Tainan (TW)
Assigned to RISE BIOPHARMACEUTICALS INC., Beijing (CN)
Filed by Rise Biopharmaceuticals Inc., Beijing (CN)
Filed on Aug. 28, 2020, as Appl. No. 17/006,512.
Application 17/006,512 is a continuation in part of application No. 15/569,033, abandoned, previously published as PCT/CN2015/008725, filed on Jun. 3, 2015.
Claims priority of provisional application 62/959,553, filed on Jan. 10, 2020.
Claims priority of provisional application 62/927,829, filed on Oct. 30, 2019.
Prior Publication US 2021/0046158 A1, Feb. 18, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/19 (2006.01); A61P 35/00 (2006.01)

CPC A61K 38/195 (2013.01) [A61P 35/00 (2018.01)]

4 Claims

1. A modified chemokine peptide, wherein the modified chemokine peptide is RP72 set forth in SEQ ID NO: 1.